These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7487132)

  • 1. [Five-day continuous intravenous infusion of cisplatin and etoposide for extensive stage small cell lung cancer].
    Okazaki M; Watanabe I; Hajiro T; Matsumoto H; Nishimura T; Hasegawa T; Katagami N; Ishihara K; Umeda B; Bandou K
    Gan To Kagaku Ryoho; 1995 Nov; 22(13):1987-9. PubMed ID: 7487132
    [No Abstract]   [Full Text] [Related]  

  • 2. [Phase II study of a continuous five-day intravenous infusion of cisplatin and etoposide with concurrent chest radiation therapy in limited stage small cell lung cancer].
    Sugita T; Matsunaga K; Kobayashi H; Horikawa S; Suzuki Y; Nishiyama H; Maekawa N; Matsumoto H; Okazaki M; Katagami N
    Gan To Kagaku Ryoho; 1994 Oct; 21(14):2479-83. PubMed ID: 7944494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary study of efficacy of intravenous cisplatin plus oral etoposide in small cell lung cancer.
    Chewaskulyong B; Thongprasert S
    J Med Assoc Thai; 1998 Jan; 81(1):37-41. PubMed ID: 9470320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Successful treatment of a pretreated elderly case of small-cell lung carcinoma with continuous five-day intravenous infusion of cisplatin plus etoposide].
    Mitsugi K; Mori T; Tamari Y; Tsuda Y; Hirata Y; Otuka T; Nakano S; Niho Y
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2341-4. PubMed ID: 1656891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of 21-day oral etoposide given in combination with i.v. cisplatin in patients with extensive-stage small cell lung cancer: a cancer and leukemia group B study (CALGB 9062).
    Miller AA; Rosner GL; Ratain MJ; Hollis DR; Green MR; Schilsky RL
    Clin Cancer Res; 1997 May; 3(5):719-25. PubMed ID: 9815741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
    Hainsworth JD; Greco FA
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.
    Ettinger DS; Berkey BA; Abrams RA; Fontanesi J; Machtay M; Duncan PJ; Curran WJ; Movsas B; Byhardt RW;
    J Clin Oncol; 2005 Aug; 23(22):4991-8. PubMed ID: 15939930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized phase II study of daily versus continuous-infusion schedules of topotecan in the treatment of extensive-stage small cell lung cancers.
    Schaefer PL; Marks RS; Mahoney MR; Sloan JA; Bauman MD; Tazelaar HD; Kugler JW; Mailliard JA; Ebbert LP; Wiesenfeld M
    Am J Clin Oncol; 2003 Jun; 26(3):236-40. PubMed ID: 12796591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-intensive chemotherapy in extensive-stage small cell lung cancer.
    Fukuoka M; Masuda N; Takada M; Kodama N; Kawahara M; Furuse K
    Semin Oncol; 1994 Feb; 21(1 Suppl 1):43-7. PubMed ID: 7512276
    [No Abstract]   [Full Text] [Related]  

  • 10. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
    Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Aamdal S;
    Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open-label, multicenter, randomized, phase III study comparing oral topotecan/cisplatin versus etoposide/cisplatin as treatment for chemotherapy-naive patients with extensive-disease small-cell lung cancer.
    Eckardt JR; von Pawel J; Papai Z; Tomova A; Tzekova V; Crofts TE; Brannon S; Wissel P; Ross G
    J Clin Oncol; 2006 May; 24(13):2044-51. PubMed ID: 16648504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Etoposide and cisplatin combination chemotherapy in a patient with small cell lung carcinoma under artificial hemodialysis].
    Ono S; Miyazaki T; Nishikawa K; Watanabe K; Hisanaga S
    Gan To Kagaku Ryoho; 1992 Jan; 19(1):115-8. PubMed ID: 1309629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
    Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
    Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pilot study of a continuous five-day intravenous infusion of cisplatin plus vindesine in advanced non-small cell lung cancer].
    Mori K; Saito Y; Yokoi K; Tominaga K; Miyazawa N
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2465-8. PubMed ID: 2546506
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101).
    Tsuchiya R; Suzuki K; Ichinose Y; Watanabe Y; Yasumitsu T; Ishizuka N; Kato H
    J Thorac Cardiovasc Surg; 2005 May; 129(5):977-83. PubMed ID: 15867769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
    Kelly K; Pan Z; Wood ME; Murphy J; Bunn PA
    Clin Cancer Res; 1999 Nov; 5(11):3419-24. PubMed ID: 10589753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study of cisplatin, etoposide, and paclitaxel in patients with extensive-stage small cell lung cancer: a University of Colorado Cancer Center study.
    Bunn PA; Kelly K
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):11-5. PubMed ID: 9007114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised phase II study of the efficacy and safety of intravenous topotecan in combination with either cisplatin or etoposide in patients with untreated extensive disease small-cell lung cancer.
    Quoix E; Breton JL; Gervais R; Wilson J; Schramel F; Cardenal F; Ross G; Preston A; Lymboura M; Mattson K
    Lung Cancer; 2005 Aug; 49(2):253-61. PubMed ID: 16022920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of oral etoposide and intravenous paclitaxel in extensive-stage small cell lung cancer.
    Perez EA; Geoffroy FJ; Hillman S; Johnson EA; Farr GH; Tazelarr HD; Hatfield AK; Krook JE; Maillard JA; Levitt R; Marks RS
    Lung Cancer; 2004 Jun; 44(3):347-53. PubMed ID: 15140548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A combination chemotherapy of cisplatin and etoposide in small cell lung cancer].
    Saito R; Tsuchiya S; Minato K; Ishizuka T
    Nihon Gan Chiryo Gakkai Shi; 1988 Mar; 23(3):744-51. PubMed ID: 2841389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.